Evoke Pharma (EVOK) Tops Q4 EPS by 8c

Evoke Pharma (NASDAQ: EVOK) reported Q4 EPS of ($0.37), $0.08 better than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• St. James's Place plc (STJ:LN) (STJPF) PT Raised to GBP20.50 at Deutsche Bank
• Worthington Industries (WOR) Misses Q4 EPS by 9c